Important message regarding NAMENDA® (memantine HCl). Forest plans to discontinue the general sale and distribution of NAMENDA 5 mg and 10 mg tablets, beginning in January 2015. This is not due to any safety or efficacy issue related to NAMENDA tablets. More information will be available in the coming weeks about the plans to make Namenda tablets available through specialty pharmacy home delivery for patients whose physician indicates medical need.
The oral solution of NAMENDA will continue to be available, along with NAMENDA XR® (memantine HCl) extended‑release capsules.